passlisted in Coinbasefirst observed 2026-09-28
0.005 USDC
per call, as the listing declares it on eip155:
- Validation state
- pass
- Uptime, 7 / 30 / 90 days
- 100% / 100% / 100%
- Calls, trailing 30 days
- —
- Unique payers, trailing 30 days
- —
- Last called
- 2026-09-28 12:05 UTC
- First observed by TOLLderived
- 2026-09-28
- Pricederived
- 0.005 USDC
- Networks
- 1
How has the volume on this endpoint moved?
calc hfa icos vegf is one of 844 listed endpoints on api.magentlab.com, one without counters among them.
The request to calc hfa icos vegf is a JSON body with the field items.
A response from calc hfa icos vegf, as declared, includes path, count and items.
On this snapshot the call counter for calc hfa icos vegf is absent while the last-call timestamp reads 2026-09-28; absent is not zero.
Per call, calc hfa icos vegf declares 0.005 USDC on Base.
TOLL files calc hfa icos vegf under the "other" category: a POST endpoint on api.magentlab.com, listed in the Coinbase registry.
calc hfa icos vegf answered the sweep of 2026-10-12 with a valid 402, as at every sweep since 2026-09-28.
Closest in price to calc hfa icos vegf within the "other" category: enrich profile at win.oneshotagent.com and ping at www.api-xpay.com.
calc hfa icos vegf is priced above 31% of comparable listings in the "other" category.
The wallet paid by calc hfa icos vegf is the payee of 844 endpoints on one host.
The seller's tags on calc hfa icos vegf are hfa-icos, vegf-inhibitor, cardio-oncology and lyon-2020.
It disappeared from the registry on 2026-09-30 and returned on 2026-09-30.
The price of calc hfa icos vegf is declared by 770 other listings in the "other" category too.
the payment options, as of 2026-10-12 15:20 UTC · method · pinnable
| registry | network | asset | amount | scheme | pay to |
|---|---|---|---|---|---|
| Coinbase | eip155: | USDC | 0.005 USDC | exact | 0x836Be2…c19Ee2 |
the checks, as of 2026-10-12 06:12 UTC · method · pinnableendpoint answered HTTP 402
No named check failed.
Every sweep that observed this endpoint, newest first.
| observed, UTC | state | failed checks | sweep |
|---|---|---|---|
| 2026-10-12 06:12 UTC | pass | 0 | daily-2026-10-12 |
| 2026-10-11 04:35 UTC | pass | 0 | daily-2026-10-11 |
| 2026-10-10 09:51 UTC | pass | 0 | daily-2026-10-10 |
| 2026-10-09 04:36 UTC | pass | 0 | daily-2026-10-09 |
| 2026-10-08 06:13 UTC | pass | 0 | daily-2026-10-08 |
| 2026-10-07 04:47 UTC | pass | 0 | daily-2026-10-07 |
| 2026-10-06 06:16 UTC | pass | 0 | daily-2026-10-06 |
| 2026-10-05 06:03 UTC | pass | 0 | daily-2026-10-05 |
| 2026-10-04 08:53 UTC | pass | 0 | daily-2026-10-04 |
| 2026-10-03 04:13 UTC | pass | 0 | daily-2026-10-03 |
| 2026-10-02 13:22 UTC | pass | 0 | daily-2026-10-02 |
| 2026-10-01 06:36 UTC | pass | 0 | daily-2026-10-01 |
| 2026-09-30 05:54 UTC | pass | 0 | daily-2026-09-30 |
| 2026-09-29 18:15 UTC | pass | 0 | daily-2026-09-29 |
| 2026-09-28 16:52 UTC | pass | 0 | daily-2026-09-28 |
| 2026-09-28 15:07 UTC | pass | 0 | new-after-daily-2026-09-28 |
Presence in a registry, not liveness of the service (method). Newest first.
- back in Coinbase
- absent from Coinbase at this pull
- listed in Coinbase
From the registry record, not validated by TOLL.the declared schema, as of 2026-10-12 13:35 UTC · method · live
The input and output block
{
"input": {
"body": {
"items": [
{
"ckd": false,
"sex": "female",
"qtc_ms": 400,
"obesity": false,
"diabetes": false,
"age_years": 50,
"arrhythmia": false,
"proteinuria": false,
"elevated_bnp": false,
"hypertension": false,
"lvef_percent": 60,
"hyperlipidemia": false,
"elevated_troponin": false,
"venous_thrombosis": false,
"prior_anthracycline": false,
"arterial_vascular_disease": false,
"current_or_significant_smoker": false,
"heart_failure_or_cardiomyopathy": false,
"prior_left_chest_or_mediastinal_rt": false
},
{
"ckd": false,
"sex": "female",
"qtc_ms": 400,
"obesity": false,
"diabetes": false,
"age_years": 50,
"arrhythmia": false,
"proteinuria": false,
"elevated_bnp": false,
"hypertension": false,
"lvef_percent": 60,
"hyperlipidemia": false,
"elevated_troponin": false,
"venous_thrombosis": false,
"prior_anthracycline": false,
"arterial_vascular_disease": false,
"current_or_significant_smoker": false,
"heart_failure_or_cardiomyopathy": false,
"prior_left_chest_or_mediastinal_rt": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/hfa_icos_vegf",
"count": 2,
"items": [
{
"sex": "female",
"qtc_ms": 400,
"formula": "hfa_icos_vegf",
"citation": {
"id": "lyon-2020",
"doi": "10.1002/ejhf.1920",
"pmid": "32458582",
"title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society",
"source": "Eur J Heart Fail. 2020;22(11):1945-1960",
"authors": "Lyon AR, Dent S, Stanway S, et al."
},
"age_years": 50,
"components": [
{
"tier": "very_high",
"factor": "heart_failure_or_cardiomyopathy",
"points": 0,
"present": false
},
{
"tier": "very_high",
"factor": "arterial_vascular_disease",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "venous_thrombosis",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "lvef_lt_50",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "qtc_ge_480",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "age_ge_75",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "hypertension",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "prior_anthracycline",
"points": 0,
"present": false
},
{
"tier": "medium_2",
"factor": "lvef_50_to_54",
"points": 0,
"present": false
},
{
"tier": "medium_2",
"factor": "borderline_qtc",
"points": 0,
"present": false
},
{
"tier": "medium_2",
"factor": "arrhythmia",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "elevated_troponin",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "elevated_bnp",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "age_65_to_74",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "diabetes",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "hyperlipidemia",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "ckd",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "proteinuria",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "prior_left_chest_or_mediastinal_rt",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "current_or_significant_smoker",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "obesity",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_level": "low",
"high_factor": false,
"lvef_percent": 60,
"medium_points": 0,
"very_high_factor": false,
"formula_expression": "HFA-ICOS VEGF-inhibitor class (Lyon 2020): very_high if any very-high factor; else high if any high factor or medium_points>=5; else medium if medium_points 2-4; else low. medium_points = Medium 2 + Medium 1 only. Very high: heart_failure_or_cardiomyopathy, arterial_vascular_disease (IHD, PCI, CABG, stable angina, TIA, stroke, or PVD). High: venous_thrombosis, lvef_percent<50, qtc_ms>=480, age_years>=75, hypertension, prior_anthracycline. Medium 2: lvef 50-54, male 450<=qtc<480, female 460<=qtc<480, arrhythmia (AF/flutter/VT/VF). Medium 1: elevated_troponin, elevated_bnp, age 65-74, diabetes, hyperlipidemia, ckd, proteinuria, prior_left_chest_or_mediastinal_rt, current_or_significant_smoker, obesity. Age exclusive (>=75 High; 65-74 Medium 1; <65 none). LVEF exclusive (<50 High; 50-54 Medium 2; >=55 none). QTc exclusive (>=480 High; else sex-specific Medium 2). cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%",
"cardiotoxicity_guide": "<2%"
},
{
"sex": "female",
"qtc_ms": 400,
"formula": "hfa_icos_vegf",
"citation": {
"id": "lyon-2020",
"doi": "10.1002/ejhf.1920",
"pmid": "32458582",
"title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society",
"source": "Eur J Heart Fail. 2020;22(11):1945-1960",
"authors": "Lyon AR, Dent S, Stanway S, et al."
},
"age_years": 50,
"components": [
{
"tier": "very_high",
"factor": "heart_failure_or_cardiomyopathy",
"points": 0,
"present": false
},
{
"tier": "very_high",
"factor": "arterial_vascular_disease",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "venous_thrombosis",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "lvef_lt_50",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "qtc_ge_480",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "age_ge_75",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "hypertension",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "prior_anthracycline",
"points": 0,
"present": false
},
{
"tier": "medium_2",
"factor": "lvef_50_to_54",
"points": 0,
"present": false
},
{
"tier": "medium_2",
"factor": "borderline_qtc",
"points": 0,
"present": false
},
{
"tier": "medium_2",
"factor": "arrhythmia",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "elevated_troponin",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "elevated_bnp",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "age_65_to_74",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "diabetes",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "hyperlipidemia",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "ckd",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "proteinuria",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "prior_left_chest_or_mediastinal_rt",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "current_or_significant_smoker",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "obesity",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_level": "low",
"high_factor": false,
"lvef_percent": 60,
"medium_points": 0,
"very_high_factor": false,
"formula_expression": "HFA-ICOS VEGF-inhibitor class (Lyon 2020): very_high if any very-high factor; else high if any high factor or medium_points>=5; else medium if medium_points 2-4; else low. medium_points = Medium 2 + Medium 1 only. Very high: heart_failure_or_cardiomyopathy, arterial_vascular_disease (IHD, PCI, CABG, stable angina, TIA, stroke, or PVD). High: venous_thrombosis, lvef_percent<50, qtc_ms>=480, age_years>=75, hypertension, prior_anthracycline. Medium 2: lvef 50-54, male 450<=qtc<480, female 460<=qtc<480, arrhythmia (AF/flutter/VT/VF). Medium 1: elevated_troponin, elevated_bnp, age 65-74, diabetes, hyperlipidemia, ckd, proteinuria, prior_left_chest_or_mediastinal_rt, current_or_significant_smoker, obesity. Age exclusive (>=75 High; 65-74 Medium 1; <65 none). LVEF exclusive (<50 High; 50-54 Medium 2; >=55 none). QTc exclusive (>=480 High; else sex-specific Medium 2). cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%",
"cardiotoxicity_guide": "<2%"
}
]
}
}
}Cite this page
The pinned URL below renders this page from the snapshot of 2026-10-12 15:20 UTC and does not change; the live page does, every six hours. Data reuse is under CC BY 4.0 (terms).
Plain text
TOLL, "calc hfa icos vegf on api.magentlab.com", snapshot of 2026-10-12 15:20 UTC. https://tollindex.com/e/api-magentlab-com-api-calc-hfa-icos-vegf-175bfb/at/2026-10-12T15-20Z. Accessed [access date].
BibTeX
@misc{toll-e-api-magentlab-com-api-calc-hfa-icos-vegf-175bfb-2026-10-12T15-20Z,
author = {TOLL},
title = {calc hfa icos vegf on api.magentlab.com},
howpublished = {\url{https://tollindex.com/e/api-magentlab-com-api-calc-hfa-icos-vegf-175bfb/at/2026-10-12T15-20Z}},
year = {2026},
month = {10},
note = {Pinned view of the snapshot of 2026-10-12 15:20 UTC. Accessed [access date].}
}None yet. Anything submitted through the form below is published here with its outcome.